Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Employees

Alnylam Pharmaceuticals had 2,500 employees as of December 31, 2025. The number of employees increased by 270 or 12.11% compared to the previous year.

• Employees: 2,500
• Change (1Y): 270
• Growth (1Y): 12.11%
• Revenue / Employee: $1,485,575
• Profits / Employee: $125,499
• Market Cap: 40.74B

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	2,500	270	12.11%
Dec 31, 2024	2,230	130	6.19%
Dec 31, 2023	2,100	98	4.90%
Dec 31, 2022	2,002	337	20.24%
Dec 31, 2021	1,665	212	14.59%
Dec 31, 2020	1,453	130	9.83%
Dec 31, 2019	1,323	258	24.23%
Dec 31, 2018	1,065	316	42.19%
Dec 31, 2017	749	235	45.72%
Dec 31, 2016	514	145	39.30%
Dec 31, 2015	369	113	44.14%
Dec 31, 2014	256	91	55.15%
Dec 31, 2013	165	36	27.91%
Dec 31, 2012	129	13	11.21%
Dec 31, 2011	116	-56	-32.56%
Dec 31, 2010	172	-6	-3.37%
Dec 31, 2009	178	8	4.71%
Dec 31, 2008	170	41	31.78%
Dec 31, 2007	129	7	5.74%
Dec 31, 2006	122	28	29.79%
Dec 31, 2005	94	23	32.39%
Dec 31, 2004	71	11	18.33%
Dec 31, 2003	60	-	-

Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.